Anmeldung erfolgt in Kürze...
Details werden geladen...
Biomea Fusion Announces Poster Presentations of Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions | The Manila Times
SAN CARLOS, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. ('Biomea” or 'Biomea Fusion” or 'the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that three icovamenib abstracts have been selected for late-breaking poster presentations at the American Diabetes Association (ADA) 86th Scientific Sessions, taking place June 5-8, 2026 in New Orleans. The presentations include data from icovamenib, the Company’s investigational oral menin inhibitor, across both type 1 and type 2 diabetes, highlighting its potential to improve beta cell function and support metabolic health.
Ähnliche Seiten
Structure Therapeutics to Present Aleniglipron, Amylin and Combination Data at the American Diabetes Association 86th Scientific Sessions | The Manila Times
https://www.manilatimes.net/2026/04/28/tmt-newswire/globenewswire/structure-therapeutics-to-present-aleniglipron-amylin-and-combination-data-at-the-american-diabetes-association-86th-scientific-sessions/2329668NewAmsterdam Pharma Announces Three Presentations at the 2026 American College of Cardiology Annual Scientific Session | The Manila Times
https://www.manilatimes.net/2026/03/23/tmt-newswire/globenewswire/newamsterdam-pharma-announces-three-presentations-at-the-2026-american-college-of-cardiology-annual-scientific-session/2305490Dyne Therapeutics Announces Upcoming Presentations Across Neuromuscular Pipeline at 2026 MDA Clinical & Scientific Conference | The Manila Times
https://www.manilatimes.net/2026/02/23/tmt-newswire/globenewswire/dyne-therapeutics-announces-upcoming-presentations-across-neuromuscular-pipeline-at-2026-mda-clinical-scientific-conference/2282603Context Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026 | The Manila Times
https://www.manilatimes.net/2026/03/19/tmt-newswire/globenewswire/context-therapeutics-announces-poster-presentation-at-the-american-association-for-cancer-research-aacr-annual-meeting-2026/2303593Rgenta Therapeutics Announces Two Oral Presentations Highlighting Proprietary RSwitch Technology at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting | The Manila Times
https://www.manilatimes.net/2026/04/28/tmt-newswire/globenewswire/rgenta-therapeutics-announces-two-oral-presentations-highlighting-proprietary-rswitch-technology-at-the-american-society-of-gene-and-cell-therapy-asgct-2026-annual-meeting/2329713